Metabolite Profiles in Sepsis: Developing Prognostic Tools Based on the Type of Infection∗

Critical Care Medicine

Volumn 44, Issue 9, 2016, Pages 1649-1662

  Neugebauer, Sophie ^a   Giamarellos Bourboulis, Evangelos J ^a,b   Pelekanou, Aimilia ^b   Marioli, Androniki ^c   Baziaka, Fotini ^b   Tsangaris, Iraklis ^b   Bauer, Michael ^a   Kiehntopf, Michael ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c SISMANOGLIO HOSPITAL   (Greece)

Author keywords

diagnosis; metabolites; prognosis; sepsis; systemic inflammation

Indexed keywords

ACYLCARNITINE; BIOGENIC AMINE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLYCEROPHOSPHOLIPID; INTERLEUKIN 6; PROCALCITONIN; PUTRESCINE; SPHINGOLIPID;

ABDOMINAL INFECTION; ADULT; AGED; ARTICLE; BLOODSTREAM INFECTION; COMMUNITY ACQUIRED PNEUMONIA; EXPERIMENTAL SEPTIC SHOCK; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TANDEM MASS SPECTROMETRY; URINARY TRACT INFECTION; BLOOD; DIFFERENTIAL DIAGNOSIS; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; STATISTICAL MODEL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLOMICS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SEPSIS; YOUNG ADULT;

EID: 84964329485     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001740     Document Type: Article

References (43)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
2. Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med 2013; 369:840-851
3. Kumar A, Roberts D, Wood KE, et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596
4. Uzzan B, Cohen R, Nicolas P, et al: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis. Crit Care Med 2006; 34:1996-2003
5. Gogos C, Kotsaki A, Pelekanou A, et al: Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care 2010; 14:R96
6. Tsalik EL, Jaggers LB, Glickman SW, et al: Discriminative value of inflammatory biomarkers for suspected sepsis. J Emerg Med 2012; 43:97-106
7. Wong ML, Xie B, Beatini N, et al: Acute systemic inflammation upregulates secretory sphingomyelinase in vivo: A possible link between inflammatory cytokines and atherogenesis. Proc Natl Acad Sci U S A 2000; 97:8681-8686
8. Serkova NJ, Standiford TJ, Stringer KA: The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am J Respir Crit Care Med 2011; 184:647-655
9. Kiehntopf M, Nin N, Bauer M: Metabolism, metabolome, and metabolomics in intensive care: Is it time to move beyond monitoring of glucose and lactate? Am J Respir Crit Care Med 2013; 187:906-907
10. Mickiewicz B, Vogel HJ, Wong HR, et al: Metabolomics as a novel approach for early diagnosis of pediatric septic shock and its mortality. Am J Respir Crit Care Med 2013; 187:967-976
11. Schmerler D, Neugebauer S, Ludewig K, et al: Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients. J Lipid Res 2012; 53:1369-1375
12. Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256
13. Calandra T, Cohen J; International Sepsis Forum Definition of Infection in the ICU Consensus Conference: The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005; 33:1538-1548
14. Xia J, Psychogios N, Young N, et al: MetaboAnalyst: A web server for metabolomic data analysis and interpretation. Nucleic Acids Res 2009; 37:W652-W660
15. Youden WJ: Index for rating diagnostic tests. Cancer 1950; 3:32-35
16. Moyer MW: New biomarkers sought for improving sepsis management and care. Nat Med 2012; 18:999
17. Tang BM, Eslick GD, Craig JC, et al: Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: Systematic review and metaanalysis. Lancet Infect Dis 2007; 7:210-217
18. Kitchens RL, Thompson PA, Munford RS, et al: Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J Lipid Res 2003; 44:2339-2348
19. Hudgins LC, Parker TS, Levine DM, et al: A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. J Lipid Res 2003; 44:1489-1498
20. Khovidhunkit W, Memon RA, Feingold KR, et al: Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis 2000; 181(Suppl 3):S462-S472
21. van Leeuwen HJ, van Beek AP, Dallinga-Thie GM, et al: The role of high density lipoprotein in sepsis. Neth J Med 2001; 59:102-110
22. van Leeuwen HJ, Heezius EC, Dallinga GM, et al: Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003; 31:1359-1366
23. Hoffman JS, Benditt EP: Plasma clearance kinetics of the amyloidrelated high density lipoprotein apoprotein, serum amyloid protein (apoSAA), in the mouse. Evidence for rapid apoSAA clearance. J Clin Invest 1983; 71:926-934
24. Rohrer L, Hersberger M, von Eckardstein A: High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr Opin Lipidol 2004; 15:269-278
25. Pruzanski W, de Beer FC, de Beer MC, et al: Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2. Biochem J 1995; 309(Pt 2):461-464
26. Riedemann NC, Ward PA: Oxidized lipid protects against sepsis. Nat Med 2002; 8:1084-1085
27. Langley RJ, Tsalik EL, van Velkinburgh JC, et al: An integrated clinicometabolomic model improves prediction of death in sepsis. Sci Transl Med 2013; 5:195ra95
28. Langley RJ, Tipper JL, Bruse S, et al: Integrative "omic" analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes. Am J Respir Crit Care Med 2014; 190:445-455
29. López-Armada MJ, Riveiro-Naveira RR, Vaamonde-García C, et al: Mitochondrial dysfunction and the inflammatory response. Mitochondrion 2013; 13:106-118
30. Weber M, Lambeck S, Ding N, et al: Hepatic induction of cholesterol biosynthesis reflects a remote adaptive response to pneumococcal pneumonia. FASEB J 2012; 26:2424-2436
31. Shah P, Nanduri B, Swiatlo E, et al: Polyamine biosynthesis and transport mechanisms are crucial for fitness and pathogenesis of Streptococcus pneumoniae. Microbiology 2011; 157:504-515
32. Toufekoula C, Papadakis V, Tsaganos T, et al: Compartmentalization of lipid peroxidation in sepsis by multidrug-resistant Gram-negative bacteria: Experimental and clinical evidence. Crit Care 2013; 17:R6
33. Marcovecchio ML, Dalton RN, Turner C, et al: Symmetric dimethylarginine, an endogenous marker of glomerular filtration rate, and the risk for microalbuminuria in young people with type 1 diabetes. Arch Dis Child 2010; 95:119-124
34. Drobnik W, Liebisch G, Audebert FX, et al: Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J Lipid Res 2003; 44:754-761
35. Memon RA, Holleran WM, Moser AH, et al: Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler Thromb Vasc Biol 1998; 18:1257-1265
36. Zehethofer N, Bermbach S, Hagner S, et al: Lipid analysis of airway epithelial cells for studying respiratory diseases. Chromatographia 2015; 78:403-413
37. Giamarellos-Bourboulis EJ, Geladopoulos T, Chrisofos M, et al: Oleuropein: A novel immunomodulator conferring prolonged survival in experimental sepsis by Pseudomonas aeruginosa. Shock 2006; 26:410-416
38. Hanczar B, Hua J, Sima C, et al: Small-sample precision of ROCrelated estimates. Bioinformatics 2010; 26:822-830
39. Hajian-Tilaki K: Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med 2013; 4:627-635
40. Kamlage B, Maldonado SG, Bethan B, et al: Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. Clin Chem 2014; 60:399-412
41. Anton G, Wilson R, Yu ZH, et al: Pre-analytical sample quality: Metabolite ratios as an intrinsic marker for prolonged room temperature exposure of serum samples. PLoS One 2015; 10:e0121495
42. Abuja PM, Ehrhart F, Schoen U, et al: Alterations in human liver metabolome during prolonged cryostorage. J Proteome Res 2015; 14:2758-2768
43. Ellervik C, Vaught J: Preanalytical variables affecting the integrity of human biospecimens in biobanking. Clin Chem 2015; 61:914-934